TAPI-1

Catalog No.S7434 Batch:S743402

Print

Technical Data

Formula

C26H37N5O5

Molecular Weight 499.60 CAS No. 171235-71-5
Solubility (25°C)* In vitro DMSO 99 mg/mL (198.15 mM)
Water 99 mg/mL (198.15 mM)
Ethanol 99 mg/mL (198.15 mM)
In vivo (Add solvents to the product individually and in order)
Clear solution
5%DMSO 40%PEG300 5%Tween80 50%ddH2O
4.95mg/ml Taking the 1 mL working solution as an example, add 50 μL of 99 mg/ml clarified DMSO stock solution to 400 μL of PEG300, mix evenly to clarify it; add 50 μL of Tween80 to the above system, mix evenly to clarify; then continue to add 500 μL of ddH2O to adjust the volume to 1 mL. The mixed solution should be used immediately for optimal results. 
* <1 mg/ml means slightly soluble or insoluble.
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
* Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

Biological Activity

Description TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors. TAPI-1 is also an inhibitor of Matrix Metalloproteinase (MMP).
Targets
ADAM17/TACE [1] MMP [5]
In vitro

TAPI-1 prevents unstimulated and PMA-induced release of the soluble forms of TNF-alpha, p60 TNFR, and IL-6R from the monocytic cell line, THP-1, and from human peripheral blood monocytes. TAPI also inhibits LPS-induced shedding of the p60 TNFR and TNF-alpha from monocytes. [1]

TAPI-1 inhibits TACE-dependent constitutive release of co-transfected APP(695). [2]

TAPI-1 attenuates Ang II-induced EGFR transactivation and cell proliferation in human HSC line LI90. [3]

TAPI-1 with the EGFR inhibitor AG1478 exhibits deactivated AREG/EGFR/ERK signaling pathway and reduces pro-inflammatory cytokines release in pSS salivary gland-derived epithelial cells. [4]

In vivo

TAPI-1 is an ADAM17/TACE inhibitor, which blocks shedding of cytokine receptors

Protocol (from reference)

Cell Assay:

[3]

  • Cell lines

    LI90 cells

  • Concentrations

    20 μM

  • Incubation Time

    60 hours

  • Method

    Five thousand cells are seeded into each well of 96-well plates and their viability is assessed by CellTiter-Glo Luminescent Cell Viability assay. Upon serum deprivation for 24 h, the cells are treated with Ang II for 60 h with and without pretreatment with each inhibitor and antagonist. The assay substrates are then added to each well on the plate and the samples are evaluated using a luminometer.

Animal Study:

[6]

  • Animal Models

    Male Sprague-Dawley rats

  • Dosages

    1 μg

  • Administration

    i.c.v.

Customer Product Validation

Data from [Data independently produced by , , Sci Rep, 2017, 7:46315]

Data from [Data independently produced by , , Biochim Biophys Acta Gen Subj, 2018, 1862(9):1988-1994]

Selleck's TAPI-1 has been cited by 24 publications

Immune evasion in lung metastasis of leiomyosarcoma: upregulation of EPCAM inhibits CD8+ T cell infiltration [ Br J Cancer, 2024, 10.1038/s41416-024-02576-z] PubMed: 38291183
Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism [ PLoS Pathog, 2023, 19(9):e1011629] PubMed: 37669308
Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis [ J Transl Med, 2023, 21(1):530] PubMed: 37543570
Epithelial cell adhesion molecule (EpCAM) regulates HGFR signaling to promote colon cancer progression and metastasis [ J Transl Med, 2023, 21(1):530] PubMed: 37543570
Multiplex interrogation of the NK cell signalome reveals global downregulation of CD16 signaling during lentivirus infection through an IL-18/ADAM17-dependent mechanism [ PLoS Pathog, 2023, 19(9):e1011629] PubMed: 37669308
MiR-92a/KLF4/p110δ regulates titanium particles-induced macrophages inflammation and osteolysis [ Cell Death Discov, 2022, 8(1):197] PubMed: 35418181
The collectrin-like part of the SARS-CoV-1 and -2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17 [ FASEB J, 2022, 36(3):e22234] PubMed: 35199397
Targeting the EGFR-ERK axis using the compatible solute ectoine to stabilize CFTR mutant F508del [ FASEB J, 2022, 36(5):e22270] PubMed: 35412656
Complete abrogation of key osteoclast markers with a membrane-anchored tissue inhibitor of metalloproteinase : a novel approach in the prevention of osteoclastogenesis [ Bone Joint Res, 2022, 11(11):763-776] PubMed: 36331083
Dynamic Alteration in HLA-E Expression and Soluble HLA-E via Interaction with Natural Killer Cells in Gastric Cancer [ Ann Surg Oncol, 2022, 10.1245/s10434-022-12505-0] PubMed: 36149610

RETURN POLICY
Selleck Chemical’s Unconditional Return Policy ensures a smooth online shopping experience for our customers. If you are in any way unsatisfied with your purchase, you may return any item(s) within 7 days of receiving it. In the event of product quality issues, either protocol related or product related problems, you may return any item(s) within 365 days from the original purchase date. Please follow the instructions below when returning products.

SHIPPING AND STORAGE
Selleck products are transported at room temperature. If you receive the product at room temperature, please rest assured, the Selleck Quality Inspection Department has conducted experiments to verify that the normal temperature placement of one month will not affect the biological activity of powder products. After collecting, please store the product according to the requirements described in the datasheet. Most Selleck products are stable under the recommended conditions.

NOT FOR HUMAN, VETERINARY DIAGNOSTIC OR THERAPEUTIC USE.